NM_181078.3:c.786-170T>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_181078.3(IL21R):​c.786-170T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 151,874 control chromosomes in the GnomAD database, including 9,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9558 hom., cov: 31)

Consequence

IL21R
NM_181078.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.590

Publications

2 publications found
Variant links:
Genes affected
IL21R (HGNC:6006): (interleukin 21 receptor) The protein encoded by this gene is a cytokine receptor for interleukin 21 (IL21). It belongs to the type I cytokine receptors, and has been shown to form a heterodimeric receptor complex with the common gamma-chain, a receptor subunit also shared by the receptors for interleukin 2, 4, 7, 9, and 15. This receptor transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells. The ligand binding of this receptor leads to the activation of multiple downstream signaling molecules, including JAK1, JAK3, STAT1, and STAT3. Knockout studies of a similar gene in mouse suggest a role for this gene in regulating immunoglobulin production. Three alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
IL21R Gene-Disease associations (from GenCC):
  • immunodeficiency disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cryptosporidiosis-chronic cholangitis-liver disease syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-27445837-T-G is Benign according to our data. Variant chr16-27445837-T-G is described in ClinVar as Benign. ClinVar VariationId is 1251522.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.475 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181078.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL21R
NM_181078.3
MANE Select
c.786-170T>G
intron
N/ANP_851564.1
IL21R
NM_181079.5
c.852-170T>G
intron
N/ANP_851565.4
IL21R
NM_021798.4
c.786-170T>G
intron
N/ANP_068570.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL21R
ENST00000337929.8
TSL:1 MANE Select
c.786-170T>G
intron
N/AENSP00000338010.3
IL21R
ENST00000395754.4
TSL:1
c.786-170T>G
intron
N/AENSP00000379103.4
IL21R
ENST00000564089.5
TSL:5
c.786-170T>G
intron
N/AENSP00000456707.1

Frequencies

GnomAD3 genomes
AF:
0.344
AC:
52198
AN:
151756
Hom.:
9523
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.480
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.295
Gnomad ASJ
AF:
0.271
Gnomad EAS
AF:
0.107
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.342
Gnomad MID
AF:
0.334
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.322
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.344
AC:
52269
AN:
151874
Hom.:
9558
Cov.:
31
AF XY:
0.344
AC XY:
25539
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.480
AC:
19881
AN:
41382
American (AMR)
AF:
0.294
AC:
4498
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.271
AC:
940
AN:
3472
East Asian (EAS)
AF:
0.107
AC:
551
AN:
5166
South Asian (SAS)
AF:
0.124
AC:
594
AN:
4802
European-Finnish (FIN)
AF:
0.342
AC:
3605
AN:
10552
Middle Eastern (MID)
AF:
0.332
AC:
97
AN:
292
European-Non Finnish (NFE)
AF:
0.312
AC:
21221
AN:
67914
Other (OTH)
AF:
0.321
AC:
677
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1766
3531
5297
7062
8828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.352
Hom.:
1528
Bravo
AF:
0.346
Asia WGS
AF:
0.157
AC:
545
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
8.1
DANN
Benign
0.60
PhyloP100
0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3093375; hg19: chr16-27457158; COSMIC: COSV61971396; COSMIC: COSV61971396; API